Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men

被引:165
作者
Engström, G [1 ]
Lind, P
Hedblad, B
Stavenow, L
Janzon, L
Lindgärde, F
机构
[1] Malmo Univ Hosp, Dept Community Med, S-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Dept Internal Med, S-20502 Malmo, Sweden
[3] Malmo Univ Hosp, Dept Vasc Dis, S-20502 Malmo, Sweden
关键词
stroke; myocardial infarction; cholesterol; inflammation; epidemiology;
D O I
10.1161/01.CIR.0000017327.69909.FF
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Although cholesterol is a major cardiovascular risk factor, its association with stroke remains controversial. This study explored whether the cholesterol-related incidence of stroke and myocardial infarction is modified by plasma markers of inflammation in a large, population-based cohort with a long follow-up. Methods and Results-Plasma cholesterol and 5 inflammation-sensitive plasma proteins (ISP) (fibrinogen, alpha(1)-antitrypsin, haptoglobin, ceruloplasmin, and orosomucoid) were determined in 6063 healthy men, 28 to 61 years of age. The incidence of stroke, cardiac events (fatal and nonfatal), and cardiovascular deaths was compared between groups defined by levels of cholesterol and ISP. Mean follow-up was 18.7 years. High ISP level was defined as 2 to 5 ISP in the top quartile. High cholesterol was associated with higher levels of ISP. Hypercholesterolemia (greater than or equal to6.5 mmol/L, 251 mg/dL) was associated with an increased incidence of ischemic stroke and cardiac events and with a reduced incidence of intracerebral hemorrhage. The ISP levels modified these associations. After risk factor adjustment, men with hypercholesterolemia and high ISP levels had a significantly higher risk of cardiovascular death (relative risk [RR] = 2.4; CI, 1.8 to 3.3), cardiac events (RR=2.3; CI, 1.8 to 3.0), and ischemic stroke (RR=2.1; CI, 1.4 to 3.3) than men with normal cholesterol and low ISP levels. In the absence of high ISP levels, hypercholesterolemia was associated with a moderately higher risk of cardiovascular death (RR=1.4; CI, 1.0 to 2.0) and cardiac events (RR=1.5; CI, 1.2 to 1.9) but not significantly with ischemic stroke (RR=1.25; CI, 0.8 to 2.0). Conclusions-Hypercholesterolemia is associated with high plasma levels of ISP. These proteins increase the cholesterol-related incidence of cardiovascular diseases. In the absence of elevated ISP levels, no statistically confirmed association was found between hypercholesterolemia and ischemic stroke.
引用
收藏
页码:2632 / 2637
页数:6
相关论文
共 33 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   Long-term outcome of the Malmo Preventive Project:: mortality and cardiovascular morbidity [J].
Berglund, G ;
Nilsson, P ;
Eriksson, KF ;
Nilsson, JÅ ;
Hedblad, B ;
Kristenson, H ;
Lingärde, F .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (01) :19-29
[3]  
Byington RP, 2001, CIRCULATION, V103, P387
[4]   Is cholesterol a risk factor for stroke?: Yes [J].
Demchuk, AM ;
Hess, DC ;
Brass, LM ;
Yatsu, FM .
ARCHIVES OF NEUROLOGY, 1999, 56 (12) :1518-1520
[5]   Distribution and determinants of ischaemic heart disease in an urban population.: A study from the myocardial infarction register in Malmo, Sweden [J].
Engström, G ;
Berglund, G ;
Göransson, M ;
Hansen, O ;
Hedblad, B ;
Merlo, J ;
Tydén, P ;
Janzon, L .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (05) :588-596
[6]   Geographic distribution of stroke incidence within an urban population -: Relations to socioeconomic circumstances and prevalence of cardiovascular risk factors [J].
Engström, G ;
Jerntorp, I ;
Pessah-Rasmussen, H ;
Hedblad, B ;
Berglund, G ;
Janzon, L .
STROKE, 2001, 32 (05) :1098-1103
[7]  
Ernst E, 1997, Vasc Med, V2, P115
[8]  
Esmon CT, 2000, HAEMOSTASIS, V30, P34
[9]   Natural statins and stroke risk [J].
Furberg, CD .
CIRCULATION, 1999, 99 (02) :185-188
[10]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454